Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines 2006. MMWR Recomm Rep2006;55:1–94
2.
MarrazzoJM, HandsfieldHH, WhittingtonWL. Predicting chlamydial and gonococcal cervical infection: implications for management of cervictis. Obstet Gynecol2002;100:579–84
3.
MoscickiB, ShaferMA, MillsteinSG, The use and limitations of endocervical Gram stains and mucopurulent cervicitis as predictors for Chlamydia trachomatis in female adolescents. Am J Obstet Gynaecol1987;157:65–71
4.
MyziukL, RomanowskiB, BrownM. Endocervical Gram stain smears and their usefulness in the diagnosis of Chlamydia trachomatis. Sex Transm Infect2001;77:103–6
5.
MigentRP, HillierSL. Mucopurulent cervictis as a predictor of chlamydial infection and adverse pregnancy outcome. The investigators of the John Hopkins Study of cervicitis and adverse pregnancy outcome. Sex Transm Dis1992;19:198–202
6.
PeipertJF, NessRB, SoperDE, Association of lower genital tract inflammation with objective evidence of endometritis. Infect Dis Obstet Gynecol2000;8:83–7
7.
PaavonenJ, KiviatN, HolmesKK. Prevalence and manifestations of endometritis among women with cervictis. Am J Obstet Gynecol1985;173:534–43
8.
WiesenfeldHC, HillierSL, KrohnMA, Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol2002;100:456–63
SchlichtMJ, LovrichSD, SartinJS, High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin. J Clin Microbiol2004;42:4636–40
